Filling the need for trusted information on national health issues…

Tuberculosis

  • Your Selections:

Refine Results

date

Tags

TB Studies Highlight Treatment Needs, Opportunities

Center for Global Health Policy’s “Science Speaks”: TB trials highlight needs, opportunities Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, discusses results from two tuberculosis studies that “could change approaches to treatment delivery and development, but only if funding…

Tackling TB In India Requires Both Public, Private Sector Engagement

The Hindu: Fighting India’s silent epidemic Soumya Swaminathan, director of the National Institute for Research in Tuberculosis in Chennai, and Chapal Mehra, New Delhi-based writer “Over 60 percent of all Indians seek health care in the private sector, according to India’s last National Family Health Survey. … Even though parallel…

West Cannot Ignore TB Crisis In Eastern Europe, Central Asia

Huffington Post: Tuberculosis: A Crisis in Eastern Europe and Central Asia That the West Cannot Ignore Michel Kazatchkine, U.N. secretary general’s special envoy on HIV/AIDS in Eastern Europe and Central Asia “…The World Health Organization’s Euro Bureau reports that fifteen countries in [Eastern Europe and Central Asia] are among the…

TB Patients, Activists Protest Drug Shortages In New Delhi

“Tuberculosis patients and activists protested outside the federal health ministry in New Delhi Wednesday, angered at a shortage of life-saving medicines in government clinics,” the Wall Street Journal’s “India Real Time” blog reports. “Since January this year, pediatric drugs for tuberculosis have been in short supply in many Indian states,…

Wall Street Journal Examines Shortage Of TB Drugs In India

Noting “India faces a potential shortage of a critical medication for drug-resistant tuberculosis that could deepen an already acute drug-shortfall-problem in the country with the highest burden of the deadly contagious disease,” the Wall Street Journal reports, “Tuberculosis officials in several Indian states said this week that their stocks of…

Sequestration-Related Cuts Affecting CDC’s TB Research Program

In a guest post in the Center for Global Health Policy’s “Science Speaks” blog, Coco Jervis, senior U.S. and global policy associate at the Treatment Action Group, examines how sequestration-related cuts are threatening the CDC’s Tuberculosis Trials Consortium, “the leading TB clinical research collaborative in the world,” she says. “Several…

Doctors Face Challenges In Treating Drug-Resistant TB Among Children

NPR’s “Shots” blog and “All Things Considered” on Tuesday reported on the challenges of treating children with tuberculosis (TB), particularly drug-resistant TB, a “growing epidemic.” TB drugs are not designed for children, which “means they aren’t packaged in smaller doses, and may not even have been tested for child-specific effectiveness…

Essay Examines Issue Of Counterfeit, Substandard TB Drugs

“Substandard tuberculosis drugs sold by pharmacies in poor countries are a growing public health threat, but the problem could be alleviated if governments enforced [WHO] standards,” according to an essay published online by PLOS Medicine, the New York Times reports. “At pharmacies in 17 countries, the authors bought 713 samples…

NPR Series Examines How Russian Prisons Treat Drug-Resistant TB Among Inmates

In its continuing series on drug-resistant tuberculosis (TB), NPR’s “Shots” blog and “Morning Edition” examine how the Russian prison system has teamed up with the non-profit Partners In Health to fight the disease among inmates. As part of the partnership, the Siberian facility called Medical and Penal Institution Number One…

Nature Medicine Examines Impact Of Potential Budget Cuts On TB Research

Nature Medicine examines how U.S. federal spending cuts, known as sequestration, might affect tuberculosis (TB) research, focusing on the “Tuberculosis Trials Consortium (TBTC), a research nexus based in Atlanta that conducts tuberculosis clinical trials across nine countries in collaboration with the U.S. government, non-profits and drug companies.” The news service…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.